Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Jun 30

PMID 35769713

Authors

Sha She

Qian Zhang

Jinzhi Shi

Fan Yang

Kai Dai

Affiliations

Soon will be listed here.

Abstract

Autotaxin (ATX) is a secreted glycoprotein and catalyzes the hydrolysis of lysophosphatidylcholine to lysophosphatidic acid (LPA), a growth factor-like signaling phospholipid. ATX has been abundantly detected in the culture medium of various cancer cells, tumor tissues, and serum or plasma of cancer patients. Biological actions of ATX are mediated by LPA. The ATX-LPA axis mediates a plethora of activities, such as cell proliferation, survival, migration, angiogenesis, and inflammation, and participates in the regulation of various physiological and pathological processes. In this review, we have summarized the physiological function of ATX and the ATX-LPA axis in liver cancer, analyzed the role of the ATX-LPA axis in tumorigenesis and metastasis, and discussed the therapeutic strategies targeting the ATX-LPA axis, paving the way for new therapeutic developments.

Citing Articles

Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer.

Benesch M, Tang X, Brindley D, Takabe K World J Oncol. 2024; 15(1):1-13.

PMID: 38274724 PMC: 10807915. DOI: 10.14740/wjon1762.

A Review of Cyclic Phosphatidic Acid and Other Potential Therapeutic Targets for Treating Osteoarthritis.

Tsukahara T, Imamura S, Morohoshi T Biomedicines. 2023; 11(10).

PMID: 37893163 PMC: 10603845. DOI: 10.3390/biomedicines11102790.

Marginal Maternal Zinc Deficiency Produces Liver Damage and Altered Zinc Transporter Expression in Offspring Male Rats.

Gumus M, Gulbahce-Mutlu E, Unal O, Baltaci S, Unlukal N, Mogulkoc R Biol Trace Elem Res. 2023; 202(5):2133-2142.

PMID: 37656390 DOI: 10.1007/s12011-023-03824-8.

Oral Administration of Egg- and Soy-Derived Lysophosphatidylcholine Mitigated Acetylcholine Depletion in the Brain of Scopolamine-Treated Rats.

Tanaka-Kanegae R, Kimura H, Hamada K Nutrients. 2023; 15(16).

PMID: 37630808 PMC: 10458616. DOI: 10.3390/nu15163618.

Role of autotaxin in systemic lupus erythematosus.

Tsuchida Y, Shoda H, Sawada T, Fujio K Front Med (Lausanne). 2023; 10:1166343.

PMID: 37122329 PMC: 10130763. DOI: 10.3389/fmed.2023.1166343.

References

Ishii S, Hirane M, Fukushima K, Tomimatsu A, Fukushima N, Tsujiuchi T . Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells. Biochem Biophys Res Commun. 2015; 461(1):59-64. DOI: 10.1016/j.bbrc.2015.03.169. View

Memet I, Tsalkidou E, Tsaroucha A, Lambropoulou M, Chatzaki E, Trypsianis G . Autotaxin Expression in Hepatocellular Carcinoma. J Invest Surg. 2017; 31(5):359-365. DOI: 10.1080/08941939.2017.1331280. View

Farquhar M, Humphreys I, Rudge S, Wilson G, Bhattacharya B, Ciaccia M . Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication. J Hepatol. 2017; 66(5):919-929. DOI: 10.1016/j.jhep.2017.01.009. View

Verslype C, Rosmorduc O, Rougier P . Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7:vii41-8. DOI: 10.1093/annonc/mds225. View

Xia S, Pan Y, Liang Y, Xu J, Cai X . The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 2020; 51:102610. PMC: 7000339. DOI: 10.1016/j.ebiom.2019.102610. View

Ptaszynska M, Pendrak M, Stracke M, Roberts D . Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration. Mol Cancer Res. 2010; 8(3):309-21. PMC: 2841699. DOI: 10.1158/1541-7786.MCR-09-0288. View

Magkrioti C, Oikonomou N, Kaffe E, Mouratis M, Xylourgidis N, Barbayianni I . The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis. Cancer Res. 2018; 78(13):3634-3644. DOI: 10.1158/0008-5472.CAN-17-3797. View

Lopane C, Agosti P, Gigante I, Sabba C, Mazzocca A . Implications of the lysophosphatidic acid signaling axis in liver cancer. Biochim Biophys Acta Rev Cancer. 2017; 1868(1):277-282. DOI: 10.1016/j.bbcan.2017.06.002. View

Yang S, Lee J, Park C, Kim S, Hong S, Chung H . Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis. 2002; 19(7):603-8. DOI: 10.1023/a:1020950420196. View

10.

Lee J, Park S, Lee E, Park C, Chung H, Rha S . Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression. Clin Cancer Res. 2006; 12(21):6351-8. DOI: 10.1158/1078-0432.CCR-06-1252. View

11.

Sokolov E, Eheim A, Ahrens W, Walling T, Swet J, McMillan M . Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. J Surg Res. 2012; 180(1):104-13. DOI: 10.1016/j.jss.2012.10.054. View

12.

Zhang X, Li M, Yin N, Zhang J . The Expression Regulation and Biological Function of Autotaxin. Cells. 2021; 10(4). PMC: 8073485. DOI: 10.3390/cells10040939. View

13.

Sevastou I, Kaffe E, Mouratis M, Aidinis V . Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta. 2012; 1831(1):42-60. DOI: 10.1016/j.bbalip.2012.07.019. View

14.

Erstad D, Tager A, Hoshida Y, Fuchs B . The autotaxin-lysophosphatidic acid pathway emerges as a therapeutic target to prevent liver cancer. Mol Cell Oncol. 2017; 4(3):e1311827. PMC: 5462520. DOI: 10.1080/23723556.2017.1311827. View

15.

Zuckerman V, Sokolov E, Swet J, Ahrens W, Showlater V, Iannitti D . Expression and function of lysophosphatidic acid receptors (LPARs) 1 and 3 in human hepatic cancer progenitor cells. Oncotarget. 2015; 7(3):2951-67. PMC: 4823083. DOI: 10.18632/oncotarget.6696. View

16.

Zheng X, Jia Y, Qiu L, Zeng X, Xu L, Wei M . A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. J Biol Chem. 2020; 295(6):1474-1488. PMC: 7008366. DOI: 10.1074/jbc.RA119.009899. View

17.

Xu M, Liu Z, Wang C, Yao B, Zheng X . EDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling. Oncotarget. 2017; 8(39):66154-66168. PMC: 5630400. DOI: 10.18632/oncotarget.19825. View

18.

Kraljic K, Jelic D, Ziher D, Cvrtila A, Dragojevic S, Sinkovic V . Benzoxaboroles-Novel Autotaxin Inhibitors. Molecules. 2019; 24(19). PMC: 6804080. DOI: 10.3390/molecules24193419. View

19.

Lee S, Fujiwara Y, Liu J, Yue J, Shimizu Y, Norman D . Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis. Mol Cancer Res. 2014; 13(1):174-85. PMC: 4297753. DOI: 10.1158/1541-7786.MCR-14-0263. View

20.

Tigyi G, Yue J, Norman D, Szabo E, Balogh A, Balazs L . Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis. Adv Biol Regul. 2018; 71:183-193. PMC: 6433480. DOI: 10.1016/j.jbior.2018.09.008. View